Warning: The NCBI web site requires JavaScript to function. more...
Controlling the angiogenic switch in developing atherosclerotic plaques: possible targets for therapeutic intervention.
Slevin M, Krupinski J, Badimon L.
J Angiogenes Res. 2009 Sep 21;1:4.
Related citations
Final Report on Carcinogens Background Document for Formaldehyde.
National Toxicology Program.
Rep Carcinog Backgr Doc. 2010 Jan;(10-5981):i-512.
CD105 positive neovessels are prevalent in early stage carotid lesions, and correlate with the grade in more advanced carotid and coronary plaques.
Luque A, Slevin M, Turu MM, Juan-Babot O, Badimon L, Krupinski J.
J Angiogenes Res. 2009 Sep 21;1:6.
Combining nanotechnology with current biomedical knowledge for the vascular imaging and treatment of atherosclerosis.
Slevin M, Badimon L, Grau-Olivares M, Ramis M, Sendra J, Morrison M, Krupinski J.
Mol Biosyst. 2010 Mar;6(3):444-50. Epub 2009 Nov 12. Review.
Inflammatory angiogenesis in atherogenesis--a double-edged sword.
Ribatti D, Levi-Schaffer F, Kovanen PT.
Ann Med. 2008;40(8):606-21. Review.
Growth factor therapy in atherosclerotic disease-friend or foe.
Hoefer IE, Timmers L, Piek JJ.
Curr Pharm Des. 2007;13(17):1803-10. Review.
Role of angiogenesis in cardiovascular disease: a critical appraisal.
Khurana R, Simons M, Martin JF, Zachary IC.
Circulation. 2005 Sep 20;112(12):1813-24. Review.
Identification of a 'snapshot' of co-expressed angiogenic markers in laser-dissected vessels from unstable carotid plaques with targeted arrays.
Slevin M, Turu MM, Rovira N, Luque A, Baldellou M, Krupinski J, Badimon L.
J Vasc Res. 2010;47(4):323-35. Epub 2009 Dec 16.
Changes in Hyaluronan Metabolism and RHAMM Receptor Expression Accompany Formation of Complicated Carotid Lesions and May be Pro-Angiogenic Mediators of Intimal Neovessel Growth.
Krupinski J, Ethirajan P, Font MA, Turu MM, Gaffney J, Kumar P, Slevin M.
Biomark Insights. 2008 May 12;2:361-7.
Final Report on Carcinogens Background Document for Styrene.
Rep Carcinog Backgr Doc. 2008 Sep;(8-5978):i-398.
C-reactive protein exerts angiogenic effects on vascular endothelial cells and modulates associated signalling pathways and gene expression.
Turu MM, Slevin M, Matou S, West D, Rodríguez C, Luque A, Grau-Olivares M, Badimon L, Martinez-Gonzalez J, Krupinski J.
BMC Cell Biol. 2008 Sep 2;9:47.
Angiogenesis as risk factor for plaque vulnerability.
Di Stefano R, Felice F, Balbarini A.
Curr Pharm Des. 2009;15(10):1095-106. Review.
Plaque angiogenesis and atherosclerosis.
Moulton KS.
Curr Atheroscler Rep. 2001 May;3(3):225-33. Review.
CD40 signaling in vascular cells: a key role in atherosclerosis?
Mach F, Schönbeck U, Libby P.
Atherosclerosis. 1998 Apr;137 Suppl:S89-95. Review.
Elimination of neoangiogenesis for plaque stabilization: is there a role for local drug therapy?
Kolodgie FD, Narula J, Yuan C, Burke AP, Finn AV, Virmani R.
J Am Coll Cardiol. 2007 May 29;49(21):2093-101. Epub 2007 May 17. Review.
CD40 ligand+ microparticles from human atherosclerotic plaques stimulate endothelial proliferation and angiogenesis a potential mechanism for intraplaque neovascularization.
Leroyer AS, Rautou PE, Silvestre JS, Castier Y, Lesèche G, Devue C, Duriez M, Brandes RP, Lutgens E, Tedgui A, Boulanger CM.
J Am Coll Cardiol. 2008 Oct 14;52(16):1302-11.
[Pathophysiological bases of unstable coronary syndrome].
Waltenberger J.
Herz. 2001 Apr;26 Suppl 1:2-8. German.
Carotid plaque instability and ischemic symptoms are linked to immaturity of microvessels within plaques.
Dunmore BJ, McCarthy MJ, Naylor AR, Brindle NP.
J Vasc Surg. 2007 Jan;45(1):155-9.
Novel concepts in atherogenesis: angiogenesis and hypoxia in atherosclerosis.
Sluimer JC, Daemen MJ.
J Pathol. 2009 May;218(1):7-29. Review.
Vasa vasorum and atherosclerosis - Quid novi?
Langheinrich AC, Kampschulte M, Buch T, Bohle RM.
Thromb Haemost. 2007 Jun;97(6):873-9. Review.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on